Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Dis Esophagus ; 32(7)2019 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-30596963

RESUMEN

Endoluminal vacuum therapy (EVT) is an accepted treatment for anastomotic leakage (AL) after esophagectomy. A novel concept is to use this technology in a preemptive setting, with the aim to reduce the AL rate and postoperative morbidity. Preemptive EVT (pEVT) was performed intraoperatively in 19 consecutive patients undergoing minimally invasive esophagectomy, immediately after completion of esophagogastrostomy. Twelve patients (63%) were high-risk cases with severe comorbidity. The EVT device was removed routinely three to six (median 5) days after esophagectomy. The endpoints of this study were AL rate and postoperative morbidity. There were 20 anastomoses at risk in 19 patients. One patient (5.3%) experienced major morbidity (Clavien-Dindo grade IIIb) unrelated to anastomotic healing. He underwent open reanastomosis at postoperative day 12 with pEVT for redundancy of the gastric tube and failure of transition to oral diet. Mortality after 30 days was 0% and anastomotic healing was uneventful in 19/20 anastomoses (95%). One minor contained AL healed after a second course of EVT. Except early proximal dislodgement in one patient, there were no adverse events attributable to pEVT. The median comprehensive complication index 30 days after surgery was 20.9 (IQR 0-26.2). PEVT appears to be a safe procedure that may have the potential to improve surgical outcome in patients undergoing esophagectomy.


Asunto(s)
Fuga Anastomótica/prevención & control , Esofagectomía/efectos adversos , Anciano , Fuga Anastomótica/etiología , Esofagectomía/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tapones Quirúrgicos de Gaza , Vacio , Cicatrización de Heridas
2.
Ther Umsch ; 47(1): 55-62, 1990 Jan.
Artículo en Alemán | MEDLINE | ID: mdl-2155480

RESUMEN

Neuropathy, arterial obstruction and infection are involved to varying degrees in the development of the 'diabetic foot'. A careful diagnosis is necessary in order to comprehend the various noxa and to introduce the adequate therapy. In case of the predominantly neuropathic foot with malum perforans, one must essentially proceed in a conservative way; only cornea callosities and osteomyelitic parts must be removed. In case of the predominantly angiopathic foot, revascularizing measures are most important. After improving the blood flow, the necrotic parts of the foot are sparingly resected. As prevention of a possible relapse, two things are necessary: accurately fitted shoes in order to prevent pressure points, and extremely careful foot care in order to prevent infections.


Asunto(s)
Angiopatías Diabéticas/etiología , Neuropatías Diabéticas/etiología , Pie/irrigación sanguínea , Isquemia/etiología , Enfermedades del Sistema Nervioso Periférico/etiología , Pie/inervación , Humanos , Factores de Riesgo
3.
Ther Umsch ; 53(12): 958-63, 1996 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-9036574

RESUMEN

Neuropathy, arterial obstruction and infection are involved to varying degrees in the development of the "diabetic foot". A careful diagnosis is necessary in order to comprehend the various noxa and to introduce the adequate therapy. In case of the predominantly neuropathic foot with malum perforans, one must essentially proceed in a conservative way; only callosities and osteomyelitic parts must be removed. In case of the predominantly angiopathic foot, revascularizing measures are most important. After improving the blood flow, the necrotic parts of the foot are sparingly resected. As prevention of a possible relapse, two things are necessary: accurately fitted shoes in order to prevent pressure points, and extremely careful foot care in order to prevent infections.


Asunto(s)
Pie Diabético/diagnóstico , Pie Diabético/terapia , Callosidades/cirugía , Gangrena/cirugía , Humanos , Higiene , Osteomielitis/cirugía , Zapatos
4.
Schweiz Rundsch Med Prax ; 79(41): 1192-8, 1990 Oct 09.
Artículo en Francés | MEDLINE | ID: mdl-2237045

RESUMEN

When insulin was introduced in medical therapy in 1922, it permitted to save diabetics from premature death; however, it has allowed, after a certain period of time, for the appearance of a cohort of chronic complications connected more or less specifically to the degree of hyperglycemia. After a short review of the pathophysiology of the microangiopathy, the authors have tried to demonstrate, on the basis of numerous prospective and retrospective studies in the human as well as in the animal, that an important relationship exists between the degree of glycemic control and the severity of the classical complications, retinopathy, neuropathy and nephropathy. However, the most recent studies have stressed the role of some other factors, not well established in the past, as for example the potential negative impact on retinopathy of rapid normalization of glycemia, following a long period of poor metabolic control. Likewise, high blood pressure, smoking, genetic background, as well as probably also excess of protein intake, do play an important etiopathogenic role. Thus, the simplistic equation hyperglycemia = complications is not completely valid. Microangiopathic risk in insulin-dependent diabetics seems to be low as long as their HbAlc is below 7.5%, and they do not have hypertension and do not abuse tobacco. Finally, the general approach to therapy is redefined: Try to get as close as possible to near-normoglycemia by multiple insulin injections, without causing, however, major hypoglycemia; this should be done very early after the onset of the disease.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Diabetes Mellitus/terapia , Animales , Glucemia/análisis , Complicaciones de la Diabetes , Diabetes Mellitus/sangre , Angiopatías Diabéticas/terapia , Nefropatías Diabéticas/terapia , Neuropatías Diabéticas/terapia , Retinopatía Diabética/terapia , Humanos , Hipoglucemiantes/uso terapéutico
5.
Rev. psiquiatr. infanto-juv ; 33(3): 414-427, 2016. tab
Artículo en Español | IBECS (España) | ID: ibc-185816

RESUMEN

Introducción: A pesar de que los tratamientos establecidos para mejorar los síntomas del TDAH han demostrado alivio sintomático significativo, es poco lo que se conoce sobre el efecto de los psicoestimulantes sobre el desarrollo psicosocial del niño y la potencial mejoría del deterioro funcional del paciente en todos los ámbitos de su vida diaria. Objetivos: El objetivo principal de este estudio es evaluar el impacto del tratamiento farmacológico con psicoestimulantes en el deterioro funcional, las dificultades psicosociales y la calidad de vida de los pacientes diagnosticados de TDAH. Material y métodos: Se realizó un estudio descriptivo, prospectivo, de una serie de casos, donde la población de estudio fueron 13 niños de entre 6 y 16 años, diagnosticados de TDAH en el Complejo Hospitalario Universitario de Canarias y que requerían comenzar tratamiento farmacológico con psicoestimulantes (Metilfenidato). El deterioro funcional y la calidad de vida fueron evaluados en respuesta al tratamiento pautado mediante dos instrumentos de valoración psicológica específicos para este trastorno: la Escala de Impresión Global de las Dificultades Percibidas (GIPD) y la Escala de Clasificación del Deterioro Funcional de Weiss (WFIRS). Resultados: La evaluación de la puntuación total de las escalas GIPD y WFIRS efectuadas por los padres mostró mejoría en el desarrollo psicosocial entre el momento previo al tratamiento y tras ocho semanas de terapia farmacológica psicoestimulante. El estudio estadístico mostró un p-valor =0,000241 para las dificultades percibidas con la escala GIPD y un p =0,000152 para los cambios percibidos con la escala WFIRS, mostrando, por tanto, diferencias estadísticamente significativas. Conclusión: En función de las respuestas de los padres obtenidas en las escalas, establecemos que los beneficios del tratamiento diario con psicoestimulantes en los niños con TDAH se extienden más allá del alivio de los síntomas e impacta positivamente en la función psicosocial diaria de los pacientes, así como en su calidad de vida


Introduction: Although established treatments to improve symptoms of ADHD have shown significant symptomatic relief, there's little research on the effect that psychostimulants make on the psychosocial development of children and also on the potential improvement of functional impairment of the patients in all areas of their daily life. Objectives: The purpose of this study is to evaluate the impact of treatment with psychostimulants on the functional impairment, psychosocial difficulties and quality of life in children diagnosed with ADHD. Data and methods: This prospective, descriptive study examined a series of cases of 13 children aged 6 to 16 years, diagnosed with ADHD at the University Hospital of the Canary Islands who required to begin treatment with psychostimulants (methylphenidate). Functional impairment and quality of life were evaluated in response to the treatment prescribed by two specific psychological instruments for this disorder: The Global Impression of Perceived Difficulties Scale (GIPD) and The Weiss Functional Impairment Rating Scale (WFIRS). Results: The evaluation of the total score of the GIPD and WFIRS scales rated by parents showed improvement in psychosocial development between the time prior to treatment and after eight weeks of psychostimulant drug therapy. The statistical analysis showed a p-value = 0.000241 for the ADHD-related difficulties assessed with the GIPD scale and p = 0.000152 for the ones assessed with the WFIRS scale, showing statistically significant differences. Conclusion: According to the parents who rated the scales, benefits of daily treatment with psychostimulants in children diagnosed with ADHD extend beyond symptom relief and positively impact the daily psychosocial functioning of patients as well as their quality of life


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Estimulantes del Sistema Nervioso Central/uso terapéutico , Impacto Psicosocial , Rendimiento Físico Funcional , Estudios Prospectivos , Calidad de Vida
6.
Rev. psiquiatr. infanto-juv ; 32(1): 31-48, 2015. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-185793

RESUMEN

INTRODUCCIÓN: Aunque la investigación y la experiencia clínica han demostrado que los estimulantes son fármacos eficaces para el tratamiento básico de los síntomas del TDAH, un comúnmente descrito, aunque en gran medida poco estudiado efecto secundario de este tipo de fármacos es el efecto sobre la expresión emocional de los pacientes. OBJETIVOS: El objetivo de esta investigación es evaluar el impacto del tratamiento farmacológico con Metilfenidato en la expresión afectiva de niños diagnosticados de TDAH. MATERIAL Y MÉTODOS: Se trata de un estudio descriptivo de series de casos, unicéntrico, de grupo único, donde "n" serán 15 niños diagnosticados de TDAH en el Complejo Hospitalario Universitario de Canarias, que requieran comenzar tratamiento farmacológico con metilfenidato (MPH), con una dosis diaria de al menos de 0,3 mg/Kg. Se evaluará, en dicha población, la expresión emocional, por medio de la Escala Infantil de Expresión Emocional (EESC), realizando una comparación entre el momento previo al tratamiento y un mes posterior al comienzo del mismo. RESULTADOS: La evaluación de la puntuación total de la EESC efectuada por los padres, no mostró diferencias estadísticamente significativas entre el momento previo al tratamiento y tras un mes con el mismo. Los dominios (emociones positivas, aplanamiento emocional y labilidad emocional) tampoco mostraron diferencias entre ambos períodos de tiempo, sin embargo, las emociones positivas mostraron una tendencia al descenso más llamativa que el resto, sin llegar a ser estadísticamente significativo (p = 0.0638). CONCLUSIÓN: No se han encontrado cambios estadísticamente significativos en la expresión emocional de los niños causada por el tratamiento con metilfenidato. Sin embargo, los datos muestran que existe inclinación hacia a una mejoría en la misma


INTRODUCTION: Although investigation and clinical experience have demonstrated that stimulants are effective medication for the basic treatment of the symptoms on the ADHD (Attention-Deficit/Hyperactivity Disorder), a commonly described but quite slightly studied side effect of this type of medication, is the effect on the emotional expression of patients. OBJECTIVES: The purpose of this investigation is to evaluate the effect of the treatment with Methylphenidate on the affective/emotional expression in children diagnosed with ADHD. Data and methods: It is a descriptive study of several cases series, from a center and about a unique group, where "n" will be 15 children diagnosed with ADHD at the University Hospital of the Canary Islands, who were required beginning treatment with methylphenidate (MPH), with a daily dose of at least 0,3 mg/Kg. In this study it will be evaluated the emotional expression of the group, according to the scale Expression and Emotion Scale for Children (EESC)making a comparison between the previous moment to the treatment and a subsequent month from its beginning. RESULTS: The evaluation of the total result of the EESC conducted by the parent did not show statistically significant differences between scores previously of the treatment and results after a month with it. The dominions (positive emotions, emotional flatness and emotional lability) did not show differences between both periods of time, nevertheless, the positive emotions showed a tendency of reduction more showy than the rest, without getting to be statistically significant (p = 0.0638). CONCLUSION: Statistically there have not been significant changes in the emotional expression of the children caused by the treatment with methylphenidate. Nevertheless, the data show that there is a tendency to an improvement in it


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Trastorno por Déficit de Atención con Hiperactividad/psicología , Metilfenidato/administración & dosificación , Estimulantes del Sistema Nervioso Central/administración & dosificación , Emoción Expresada/efectos de los fármacos
10.
Rev Neurol ; 47(5): 225-30, 2008.
Artículo en Español | MEDLINE | ID: mdl-18780266

RESUMEN

INTRODUCTION: There is an important agreement on the consideration of attention deficit hyperactivity disorder (ADHD) as a condition characterized by neurodevelopmental dysfunction of fronto-striatal dopaminergic and noradrenergic circuits with resultant executive deficits in cognitive functioning. AIM: To assess the existence of memory deficits in children with ADHD associated with a poor performance executive. SUBJECTS AND METHODS: We assess 14 children diagnosed with ADHD combined type and 14 controls matched on intellectual coefficient, age and level of schooling, in a neuropsychological evaluation protocol designed to assess executive functions and memory skills using Auditory Verbal Learning Test, Memory for Stories Test -Test of Memory and Learning (TOMAL)-, Complex Figure Text, Visual Selective Reminding Test (TOMAL), Tower of Hanoi, Memory Phrases Test (Siegel and Ryan), Digit Span (Wechsler Intelligence Scale for Children-Revised) and Tapping Test (Wechsler Memory Scale III). RESULTS: The ADHD group showed deficits in the learning and free recall of verbal material, in procedural and working memory. No group differences were observed in the visual memory tasks. CONCLUSIONS: The results are analyzed in terms of difficulty in coding strategies, storage and search of information previously stored in the group with ADHD, at least for the kind of verbal information. These difficulties are associated with deficits in executive functioning.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Trastornos de la Memoria/fisiopatología , Memoria/fisiología , Pruebas Neuropsicológicas , Niño , Cognición/fisiología , Trastornos del Conocimiento/fisiopatología , Femenino , Humanos , Masculino
11.
Rev Neurol ; 46(10): 602-8, 2008.
Artículo en Español | MEDLINE | ID: mdl-18465700

RESUMEN

INTRODUCTION: There is wide evidence about dopaminergic and noradrenergic mechanisms in fronto-striatal circuits which are thought to be related with attention deficit hyperactivity disorder (ADHD) neurobiology. That dysfunction may explain core symptoms and part of executive deficits in cognitive functioning. Methylphenidate is effective in alleviating core symptoms, enhancing dopaminergic and noradrenergic biodisponibility. Less evidence in improving executive functions, specially working memory is found. AIMS: To assess if methylphenidate-OROS has a potential effect increasing working memory and attention parameters in ADHD children, and to determine if initial working memory and attention differences between ADHD and control group disappear after one month of daily methylphenidate-OROS treatment. SUBJECTS AND METHODS: Eleven children with ADHD were selected and as control group was chosen eleven children compared in age, intelligence quotient, school grade, and social-demographic status. Neuropsychological battery was administered in naive ADHD patients at three times, before treatment, after the first methylphenidate-OROS dose, and after one month of daily treatment. Simultaneously neuropsychological battery was administered to control group. RESULTS. Statistically significant differences were found in neuropsychological variables of working memory after one month daily treatment with methylphenidate-OROS and attention parameters after only one dose in ADHD group. Differences between naive ADHD and control group in terms of working memory were statistically significant before treatment but not after one month daily treatment. CONCLUSION: Methylphenidate-OROS improves attention achievement after the first dose and working memory after one month of daily treatment.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Metilfenidato/uso terapéutico , Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Niño , Preparaciones de Acción Retardada , Humanos , Pruebas Neuropsicológicas
12.
Schweiz Med Wochenschr ; 109(10): 362-5, 1979 Mar 10.
Artículo en Alemán | MEDLINE | ID: mdl-570723

RESUMEN

The new MC or RI insulins are critically reviewed and the indications for switching to MC or RI pork insulin are discussed. A new means of determining the insulin requirement of brittle diabetics is short-time use of an insulin infusion apparatus.


Asunto(s)
Diabetes Mellitus/tratamiento farmacológico , Insulina/uso terapéutico , Animales , Humanos , Insulina/administración & dosificación , Insulina/clasificación , Insulina de Acción Prolongada/uso terapéutico , Porcinos , Jeringas
13.
Soc Work ; 24(6): 528-32, 1979 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10244756

RESUMEN

Whether a retarded child can be cared for at home depends primarily on the ability of his or her family to function as primary caretakers. Not surprisingly, then, the rate at which retarded children are deinstitutionalized is being slowed by this country's failure to emphasize programs that are supportive of these children's families. After examining the discrepancy between the needs of families with retarded children and services currently being provided, the author proposes various changes in policy to increase assistance and support to the family as a unit.


Asunto(s)
Desinstitucionalización , Familia , Discapacidad Intelectual/economía , Niño , Financiación Gubernamental , Política de Salud , Humanos , Estados Unidos
14.
Dtsch Med Wochenschr ; 119(22): 801-4, 1994 Jun 03.
Artículo en Alemán | MEDLINE | ID: mdl-8205942

RESUMEN

Over a period of 2 months an 88-year-old man developed progressively more severe breathing-related pain under the right shoulder blade, loss of appetite, general weakness, depressive mood, sub-febrile temperature and nocturnal sweating. Various inflammation parameters were raised (sedimentation rate 43 mm in the first hour; C-reactive protein 26 mg/dl; white cell count 12,500/microliters). There also were pleural effusion and signs of mild nonspecific hepatitis. Antibiotics were administered because bacterial pneumonia was suspected. But the patient's condition deteriorated and he developed nightly periods of disorientation. There was no evidence for any advanced malignancy. Immunological tests pointed towards older-onset systemic lupus erythematosus: titre for antinuclear antibodies markedly raised to 1:20 480; anti-DNA titre moderately raised to 1:125 IU/ml. The patient's general condition and the pleuritic pain improved within 2 days under treatment with prednisone (50 mg daily); the depression, disorientation and fever receded within a week. The anti-DNA titre fell to 47 IU/ml after 8 weeks. He was able to resume his usual social activities and was kept on a maintenance prednisone dose of 5.0 mg daily.


Asunto(s)
Lupus Eritematoso Sistémico/diagnóstico , Anciano , Anciano de 80 o más Años , Depresión/diagnóstico , Diagnóstico Diferencial , Humanos , Lupus Eritematoso Sistémico/tratamiento farmacológico , Masculino , Pleuresia/diagnóstico , Neumonía/diagnóstico , Prednisona/administración & dosificación , Neoplasias de la Próstata/diagnóstico , Inducción de Remisión , Factores de Tiempo
15.
Schweiz Med Wochenschr ; 115(4): 132-4, 1985 Jan 26.
Artículo en Alemán | MEDLINE | ID: mdl-3975580

RESUMEN

Over a two-year period 8 patients were hospitalized with a presumptive diagnosis of Candida endophthalmitis. 6 patients were heroin addicts, while in the 2 other patients no risk factor could be identified. The presumptive diagnosis was based on the typical findings of retinohyalitic exudate and exclusion of other factors causing endophthalmitis. Intravenous therapy with amphotericin-B and flucytosin resulted in definitive scar healing. In 1 patient vitrectomy was necessitated by recurrence of endophthalmitis resistant to antifungal therapy.


Asunto(s)
Candidiasis/diagnóstico , Panoftalmitis/diagnóstico , Adolescente , Adulto , Anfotericina B/uso terapéutico , Candidiasis/tratamiento farmacológico , Candidiasis/etiología , Quimioterapia Combinada , Femenino , Flucitosina/uso terapéutico , Dependencia de Heroína/complicaciones , Humanos , Masculino , Panoftalmitis/tratamiento farmacológico , Panoftalmitis/etiología
16.
Schweiz Med Wochenschr ; 108(46): 1803-6, 1978 Nov 18.
Artículo en Alemán | MEDLINE | ID: mdl-715417

RESUMEN

In view of the importance of knowing exactly how much insulin is required by diabetics who are difficult to control with subcutaneous insulin, an insulin infusion program has been tried in such patients. The apparatus, which was produced by Siemens as a prototype, works according to the following simple and flexible principle: During the day a basal rate of insulin is continuously infused. During the three main meals an additional rectangular insulin infusion is initiated by turning a knob. After an hour the apparatus switches automatically back to the basal ratio. We have used this machine in 13 patients who are fully mobile. 11 of them showed an almost ideal blood sugar profile after 4 days. After switching back to subcutaneous insulin 8 of these 11 patients did better than before but not as well as on the insulin infusion program.


Asunto(s)
Diabetes Mellitus/terapia , Insulina/administración & dosificación , Glucemia/análisis , Femenino , Humanos , Infusiones Parenterales , Masculino
17.
Horm Metab Res Suppl ; (8): 198-201, 1979.
Artículo en Inglés | MEDLINE | ID: mdl-395079

RESUMEN

11 labile diabetics were well controlled after 2 days of an i.v., open-loop insulin infusion program consisting of constant, empirically determined, basal infusion rates (mean: 1.1 U/h) and superimposed rectangular one-hour insulin infusions between 2 and 8 U/h during the main meals. The steering unit switches automatically back to the basal infusion rate after one hour. An almost optimal blood sugar profile was already obtained on the third day of the infusion program. We believe that such a flexible, open-loop insulin infusion program would render long-term optimal blood sugar control in "labile" diabetics possible if the technological development ever allows implantation of the infusion pumps.


Asunto(s)
Órganos Artificiales , Glucemia/análisis , Diabetes Mellitus/tratamiento farmacológico , Retroalimentación , Infusiones Parenterales , Insulina/administración & dosificación , Islotes Pancreáticos/metabolismo , Adolescente , Adulto , Anciano , Ingestión de Alimentos , Femenino , Humanos , Insulina/uso terapéutico , Persona de Mediana Edad , Valores de Referencia
18.
Schweiz Med Wochenschr ; 112(40): 1389-95, 1982 Oct 02.
Artículo en Alemán | MEDLINE | ID: mdl-6755694

RESUMEN

The case is reported of a 30-year-old primigravida presenting with idiopathic thrombocytopenic purpura (ITP) at 31 weeks gestation. Because the thrombocytopenia became progressively resistant to steroids, pregnancy was terminated at 36 weeks gestation by primary caesarean section after platelet transfusion. Subsequent therapy with high-dose intravenous gammaglobulin transiently reversed the thrombocytopenia. However, 3 weeks after delivery splenectomy was performed because of relapse of ITP. The baby showed only very mild, transient thrombocytopenia without clinical symptoms. Based on a literature survey covering 159 deliveries of women with ITP described in 18 publications in the period 1973-1982, the following points are discussed: 1. risk of ITP in pregnancy for mother and child (maternal mortality 0.6% per delivery, perinatal mortality 2.4%, risk of neonatal intracranial hemorrhage 2.4%), 2. therapy of ITP in pregnancy and its effects on the fetus; 3. mode of delivery; 4. perinatal management of the mother; 5. management of the newborn.


Asunto(s)
Grupo de Atención al Paciente , Complicaciones Hematológicas del Embarazo/terapia , Púrpura Trombocitopénica/terapia , Parto Obstétrico , Femenino , Humanos , Inmunoglobulina G/uso terapéutico , Recién Nacido , Masculino , Recuento de Plaquetas , Embarazo , Púrpura Trombocitopénica/tratamiento farmacológico , Esplenectomía , Esteroides/uso terapéutico
19.
Schweiz Med Wochenschr ; 111(30): 1131-5, 1981 Jul 25.
Artículo en Alemán | MEDLINE | ID: mdl-7022623

RESUMEN

The Clinitest was used to assess the effect of inpatient treatment in 24 labile insulin-dependent diabetics with a portable open loop insulin infusion device. The Clinitest results one month prior to hospitalization were compared with those during 3 months following inpatient treatment. During the first month after the hospital stay 21 patients (88%) were better controlled. Only 15 (63%) maintained better control for the whole period of 3 months. After the hospital stay the patients experienced an average of 4 more slight hypoglycemic episodes than before hospitalization. In patients who were better controlled for the whole period of 3 months the insulin dose had been adjusted considerably. Besides inadequate daily adjustment of the insulin dose, half the patients were not sufficiently motivated and did not cooperate with their diabetologists. One third of the patients did not follow a diet and one fifth practiced inadequate insulin injection techniques. These were the major causes of poor control prior to hospitalization. The results show that short term treatment with an open loop insulin infusion device is worth while for all diabetics in whom less than one third of all Clinitests are sugarfree, and also for all those in whom there are doubts about the actual insulin requirement.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Insulina/administración & dosificación , Adolescente , Adulto , Anciano , Diabetes Mellitus Tipo 1/metabolismo , Femenino , Humanos , Infusiones Parenterales/instrumentación , Masculino , Persona de Mediana Edad
20.
Int Rehabil Med ; 7(2): 76-81, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-3161842

RESUMEN

An extension of the national survey on health and medical consumption in Aquitaine used a questionnaire on presence of disability and handicap. Communication, personal cares, mobility and occupations were restricted in respectively 1.5, 3.3, 3.2, and 10.6%. People aged 60 and over were mainly concerned. Personal and domestic care disabilities were noted for 1 out of 8, communication disabilities were present among 1 out of 20. One out of 7 was restricted for mobility and physical independence; 1 out of 4 was restricted for customary occupations and 1 out of 10 for social relationships. Those physically dependent living alone were 5%.


Asunto(s)
Personas con Discapacidad , Adolescente , Adulto , Anciano , Preescolar , Francia , Encuestas Epidemiológicas , Humanos , Lactante , Recién Nacido , Persona de Mediana Edad , Distribución Aleatoria , Muestreo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA